Skin News and Research

RSS

PDL BioPharma closes financing transaction with Durata Therapeutics

PDL BioPharma, Inc. announced today that it closed a financing transaction with Durata Therapeutics, Inc., a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses.

6 Nov 2013

IUSL awarded patent for method for changing perception of skin tone

How someone perceives color is determined by how the item they are looking at scatters and emits light. In August, three City College of New York physicists affiliated with the Institute for Ultrafast Spectroscopy and Lasers (IUSL) were awarded a patent for a method for changing perception of skin tone by applying quantum and optical principles to cosmetic preparations.

6 Nov 2013

Researchers link species of intestinal bacteria to onset of rheumatoid arthritis

Researchers have linked a species of intestinal bacteria known as Prevotella copri to the onset of rheumatoid arthritis, the first demonstration in humans that the chronic inflammatory joint disease may be mediated in part by specific intestinal bacteria.

6 Nov 2013

NTU establishes new $60 million research institute in Nanomedicine

Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.

5 Nov 2013

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Boehringer Ingelheim today announced new data from its Phase III clinical trial programme, STARTVerso, which evaluates faldaprevir in combination with pegylated interferon and ribavirin (PegIFN/RBV).

5 Nov 2013

GW establishes Rodham Institute for Healthcare Provider Education to Eliminate Disparities

The George Washington University is pleased to announce the establishment of the Rodham Institute for Healthcare Provider Education to Eliminate Disparities. The Institute, which is housed within the GW School of Medicine and Health Sciences, is named in honor of the late Mrs. Dorothy E. Rodham with the vision of promoting health equity in the District of Columbia through community-focused education and training of health care providers.

5 Nov 2013

Scientists identify new algorithm to distinguish two subtypes of malignant melanoma

Scientists of the University of Ulm and Columbia University have discovered a diagnostic algorithm to distinguish two subtypes of malignant melanoma. Desmoplastic and spindle cell melanoma may look alike - they often resemble little scars or retractions of the skin - but differ in prognosis and therapeutic options.

4 Nov 2013

CHFA launches five-part guide to help Canadians make informed decisions about natural health

To celebrate Natural Health Products Week, the Canadian Health Food Association is launching a free, five-part guide aimed at helping Canadian families make informed decisions about natural health. The Canadian Family's Guide to Navigating Natural Health, was developed with nutritionist and author Lianne Phillipson-Webb.

4 Nov 2013

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

Covalon Technologies Ltd., an advanced medical technologies company, today announced that it has licensed its antimicrobial silicone adhesive technology to Molnlycke Heath Care.

4 Nov 2013

UAB experts offer advice on how to slow aging, boost self-esteem

For many men and women older than 30, the fun of birthdays fades with aging, but experts at the University of Alabama at Birmingham offer advice on how to slow aging and boost self-esteem.

4 Nov 2013

Boehringer Ingelheim's Phase II trial of interferon-free hepatitis C treatment shows promising results

Interim data presented today show that all patients (13/13) who reached their 4-week post-treatment follow-up have undetectable levels of hepatitis C virus (SVR4) after completing a 12-week regimen of faldaprevir, deleobuvir, PPI-668 and ribavirin.

4 Nov 2013

Researchers discover new model for how kidney repairs itself

Harvard Stem Cell Institute (HSCI) researchers have a new model for how the kidney repairs itself, a model that adds to a growing body of evidence that mature cells are far more plastic than had previously been imagined.

4 Nov 2013

Experimental drug effective in treating patients with non-small cell lung cancer

An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide.

4 Nov 2013

Scientists find surprising degree of variation among genomes of individual neurons

It was once thought that each cell in a person's body possesses the same DNA code and that the particular way the genome is read imparts cell function and defines the individual. For many cell types in our bodies, however, that is an oversimplification.

4 Nov 2013

Avidus Management Group provides market guidance relating to acquisition strategy

Avidus Management Group Inc. ("Avidus" or the "Company"), today provided market guidance relating to its acquisition strategy.

31 Oct 2013

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

ARIAD Pharmaceuticals, Inc. today announced that it is temporarily suspending the marketing and commercial distribution of Iclusig® (ponatinib), a treatment for patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL), in the United States, while it continues to negotiate updates to the U.S. prescribing information for Iclusig and implementation of a risk mitigation strategy.

31 Oct 2013

New finding could help lead to better treatments for eczema

For the millions of people suffering from the intensely red, horribly itchy skin condition known as eczema, the only thing more maddening than their disease is the lack of understanding of what causes it, or makes it flare up from time to time.

31 Oct 2013

Honey may be detrimental for patients with type 2 diabetes

Honey may be detrimental for patients with type 2 diabetes because of the great quantities of sugars it contains.

31 Oct 2013

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

A multidisciplinary team of experts in heart failure, cardiac arrhythmia, and neurosurgery at The Mount Sinai Hospital are now testing nerve stimulation in the neck as a novel therapy for heart failure patients to potentially help relieve their debilitating symptoms of fatigue, shortness of breath, and heart arrhythmias, while reducing their hospitalizations.

30 Oct 2013

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

An experimental new cancer drug called MK-3475, which has shown dramatic promise for treating melanoma is also showing early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death of men and women worldwide.

30 Oct 2013

Skin News and Research

PDL BioPharma closes financing transaction with Durata Therapeutics

IUSL awarded patent for method for changing perception of skin tone

Researchers link species of intestinal bacteria to onset of rheumatoid arthritis

NTU establishes new $60 million research institute in Nanomedicine

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

GW establishes Rodham Institute for Healthcare Provider Education to Eliminate Disparities

Scientists identify new algorithm to distinguish two subtypes of malignant melanoma

CHFA launches five-part guide to help Canadians make informed decisions about natural health

Covalon licenses antimicrobial silicone adhesive technology to Molnlycke Heath Care

UAB experts offer advice on how to slow aging, boost self-esteem

Boehringer Ingelheim's Phase II trial of interferon-free hepatitis C treatment shows promising results

Researchers discover new model for how kidney repairs itself

Experimental drug effective in treating patients with non-small cell lung cancer

Scientists find surprising degree of variation among genomes of individual neurons

Avidus Management Group provides market guidance relating to acquisition strategy

ARIAD temporarily suspends commercial distribution of Iclusig drug in US

New finding could help lead to better treatments for eczema

Honey may be detrimental for patients with type 2 diabetes

Multidisciplinary team tests innovative heart failure therapy in global clinical trials

Promising melanoma drug demonstrates potential for non-small cell lung cancer treatment

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News